You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NTRK gene fusion

Showing 26 - 50 of 7,543
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 16, 2023

Advanced Solid Tumor Trial in Shanghai (FCN-011)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 16, 2021

Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

Not yet recruiting
  • Advanced Cholangiocarcinoma
  • +2 more
  • (no location specified)
Feb 3, 2023

Solid Tumor Trial in United Kingdom, United States (ONO-7579)

Terminated
  • Solid Tumor
  • Lake Success, New York
  • +4 more
Sep 11, 2019

Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)

Recruiting
  • Protein Kinase Inhibitors
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Nov 9, 2023

Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

Not yet recruiting
  • Recurrent Glioblastoma, IDH-Wildtype
  • +2 more
  • Biospecimen Collection
  • +2 more
  • (no location specified)
May 13, 2023

Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Selitrectinib (BAY2731954))

Active, not recruiting
  • Solid Tumors Harboring NTRK Fusion
  • Selitrectinib (BAY2731954)
  • La Jolla, California
  • +28 more
Aug 18, 2022

Clear Cell Sarcoma Trial in El Segundo, Houston (AMG 337)

Terminated
  • Clear Cell Sarcoma
  • AMG 337
  • El Segundo, California
  • +1 more
Dec 9, 2022

Solid Tumors Harboring NTRK Fusion Trial in Mannheim (Selitrectinib (BAY2731954))

Completed
  • Solid Tumors Harboring NTRK Fusion
  • Selitrectinib (BAY2731954)
  • Mannheim, Baden-Württemberg, Germany
    CRS Clinical-Research-Services Mannheim GmbH
Dec 28, 2020

ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

Terminated
Has Results
  • ALK Fusion Protein Expression
  • +14 more
  • San Francisco, California
    University of California, San Francisco
Jan 14, 2020

Advanced Malignant Tumor, ALK Fusion Protein Expression, ALK Gene Amplification Trial in Columbus (Brigatinib, Laboratory

Withdrawn
  • Advanced Malignant Neoplasm
  • +10 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2022

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    Solid Tumors Harboring NTRK Fusion Trial in Worldwide (BAY2757556 (Larotrectinib, Vitrakvi))

    Recruiting
    • Solid Tumors Harboring NTRK Fusion
    • BAY2757556 (Larotrectinib, Vitrakvi)
    • Palo Alto, California
    • +158 more
    Aug 8, 2022

    NSCLC, Thyroid Tumors Trial (LOXO-260)

    Temporarily not available
    • Carcinoma, Non-Small-Cell Lung
    • Thyroid Neoplasms
    • (no location specified)
    Sep 20, 2022

    Cholangiocarcinoma Trial in China, Japan (E7090)

    Active, not recruiting
    • Cholangiocarcinoma
    • Bengbu, Anhui, China
    • +55 more
    Jan 24, 2023

    Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

    Recruiting
    • Solid Tumors
    • CNS Tumors
    • Orange, California
    • +38 more
    Aug 24, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Solid Tumor, Haematological Malignancy, Malignancy Trial in United Kingdom (Entrectinib)

    Recruiting
    • Solid Tumor
    • +10 more
    • Belfast, United Kingdom
    • +25 more
    Mar 14, 2023

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +44 more
    • Biopsy
    • +23 more
    • Birmingham, Alabama
    • +166 more
    Feb 2, 2023

    Solid Tumors, Adult, Solid Tumor, Mesothelioma (MPM) Trial in United States (IK-930)

    Recruiting
    • Solid Tumors, Adult
    • +7 more
    • Boston, Massachusetts
    • +6 more
    Jan 24, 2023

    BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of

    Recruiting
    • BCR-JAK2 Fusion Protein Expression
    • +11 more
    • Palo Alto, California
    • +3 more
    Oct 5, 2022

    High Risk Prostate Cancer to Determine Prognosis

    Active, not recruiting
    • Prostate Cancer
      • Gatineau, Quebec, Canada
      • +7 more
      Sep 20, 2021

      Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose

      Completed
      Has Results
      • Solid Tumor
      • Derazantinib low dose range
      • +3 more
      • Scottsdale, Arizona
      • +11 more
      Mar 7, 2022

      Non Small Cell Lung Cancer Trial in Shanghai (AB-106)

      Recruiting
      • Non Small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jun 17, 2021

      Ovarian Cancer, Carcinosarcoma Trial (Pamiparib)

      Withdrawn
      • Ovarian Cancer
      • Carcinosarcoma
      • (no location specified)
      Aug 3, 2021